Figure 4: Analysis of lymphatic vessels in uterus sections after LAM/TSC cell administration. Representative images of uterus sections showing labelling of lymphatic capillary marker LYVE-1 (green) in control mice (A), in LAM/TSC cell-administered mice (B), in LAM/TSC cell-administered mice treated with anti-EGFR antibody (C) and in LAM/TSC cell-administered mice treated with rapamycin (D) (X5). Nuclei of cells are stained with DAPI (blue). Scale bars: 400μm. Quantification of lymphatic vessels in uteri was calculated as LVD in five fields for each mouse (E). Data are expressed as mean ±SEM.